Is Mineralys Therapeutics, Inc. (MLYS) a Buy, Sell, or Hold?
Mineralys Therapeutics, Inc.
NASDAQ:MLYS
$27.28 USD
-$0.31 (-1.12%)
- Volume
- 567.55K
- Average Volume
- 1.57M
- Market Capitalization
- $1.81B
- P/E Ratio
- -13.31
- Dividend Yield
- 0.00%
- Price Target
- $43.00
- Year High
- $47.65
- Year Low
- $12.59
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $44.33
Analyst Rating
Strong Sell
1 Rating Score
UPSIDE/DOWNSIDE
-36.6% DOWNSIDE
$43.00 Price Target
UPSIDE/DOWNSIDE HIGH
-51.3% DOWNSIDE
$56.00 Price Target High
UPSIDE/DOWNSIDE LOW
-9.1% DOWNSIDE
$30.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Jefferies | Dennis Ding | $30 | $26.23 | 2026-03-13 12:40 PM | 14.4% |
| H.C. Wainwright | Matthew Caufield | $56 | $27.23 | 2026-03-10 06:12 AM | 105.7% |
| Guggenheim | Seamus Fernandez | $48 | $15.11 | 2025-05-14 08:07 AM | 217.7% |
| H.C. Wainwright | Matthew Caufield | $42 | $14 | 2025-04-02 06:13 AM | 200.0% |
| Goldman Sachs | Richard Law | $30 | $13.03 | 2024-04-01 11:18 PM | 130.2% |